Autopsy report · NCT00068302

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Recruiting/enrolling participants halted prematurely but potentially will resume”

The sponsor’s own words in the registry.

Life of this trial

Registered 8 months after it had already started.
Ran for about 10 years 6 months before it stopped.
10 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Children's Hospital of Philadelphia
Sponsor type: University, hospital or other
Conditions: Leukemia; Lymphoma
Interventions: sirolimus
Participants: 10
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.